Competition Council Finds No Violations in Medical Market, Refers Case to Ombudsman

The Competition Council (KP) has conducted an in-depth assessment of the impact of state support on competition in the medical market. During the investigation, both public and private medical institutions were analyzed to determine whether state funding for public hospitals creates unfair advantages over private providers.

After a thorough analysis, the KP found no violations of competition law. However, the council has submitted its conclusions and materials to the Ombudsman, whose competence includes evaluating issues related to equal treatment and good governance. This means that although formal competition rules have not been breached, other legal aspects may require further clarification.

The debate on public-private sector relations in healthcare in Latvia has been ongoing for several years. Private healthcare providers often argue that state support mechanisms, such as direct subsidies or preferential conditions, can distort competition. In response, public healthcare institutions emphasize their special role in providing essential and often unprofitable services, such as emergency care and treatment of rare diseases.

The KP's decision will not immediately change the market, but the involvement of the Ombudsman could lead to recommendations for policy improvements. This case highlights the need to find a balance between effective competition and the state's responsibility to ensure accessible healthcare for all citizens.